Taiwo B - Search Results

1

Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy.

Taiwo B, Yanik EL, Napravnik S, Ryscavage P, Koletar SL, Moore R, Mathews WC, Crane HM, Mayer K, Zinski A, Kahn JS, Eron JJ; CFAR Network of Integrated Clinical Systems (CNICS) Cohort Study. Taiwo B, et al. AIDS. 2013 Jun 19;27(10):1593-602. doi: 10.1097/QAD.0b013e3283601115. AIDS. 2013. PMID: 23435300 Free PMC article.

2

Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings.

Taiwo BO, Murphy R. Taiwo BO, et al. J Int Assoc Physicians AIDS Care (Chic). 2007 Sep;6(3):188-97. doi: 10.1177/1545109707300683. Epub 2007 May 1. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17473177

3

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Sax PE, Tierney C, Collier AC, Fischl MA, Mollan K, Peeples L, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Koletar SL, Johnson VA, Geiseler PJ, Daar ES; AIDS Clinical Trials Group Study A5202 Team. Sax PE, et al. N Engl J Med. 2009 Dec 3;361(23):2230-40. doi: 10.1056/NEJMoa0906768. Epub 2009 Dec 1. N Engl J Med. 2009. PMID: 19952143 Free PMC article. Clinical Trial.

4

Adherence to antiretroviral therapy: the more you look, the more you see.

Taiwo B. Taiwo B. Curr Opin HIV AIDS. 2009 Nov;4(6):488-92. doi: 10.1097/COH.0b013e3283311058. Curr Opin HIV AIDS. 2009. PMID: 20048715 Review.

5

Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.

Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Taiwo B, et al. Curr HIV Res. 2010 Apr;8(3):194-8. doi: 10.2174/157016210791111098. Curr HIV Res. 2010. PMID: 20163340

6

Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.

Taiwo B, Hicks C, Eron J. Taiwo B, et al. J Antimicrob Chemother. 2010 Jun;65(6):1100-7. doi: 10.1093/jac/dkq096. Epub 2010 Mar 25. J Antimicrob Chemother. 2010. PMID: 20348088 Review.

7

Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting.

Taiwo BO, Idoko JA, Welty LJ, Otoh I, Job G, Iyaji PG, Agbaji O, Agaba PA, Murphy RL. Taiwo BO, et al. J Acquir Immune Defic Syndr. 2010 May 1;54(1):85-92. doi: 10.1097/01.qai.0000371678.25873.1c. J Acquir Immune Defic Syndr. 2010. PMID: 20418724 Clinical Trial.

8

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C. Taiwo B, et al. Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Drugs. 2010. PMID: 20731472 Review.

9

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.

Taiwo B, Gallien S, Aga E, Ribaudo H, Haubrich R, Kuritzkes DR, Eron JJ Jr. Taiwo B, et al. J Infect Dis. 2011 Aug 15;204(4):515-20. doi: 10.1093/infdis/jir353. J Infect Dis. 2011. PMID: 21791652 Free PMC article.

10

Clinical outcomes of adolescents and young adults in adult HIV care.

Ryscavage P, Anderson EJ, Sutton SH, Reddy S, Taiwo B. Ryscavage P, et al. Among authors: taiwo b. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):193-7. doi: 10.1097/QAI.0b013e31822d7564. J Acquir Immune Defic Syndr. 2011. PMID: 21826014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters